Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-22
2005-02-22
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S196000, C544S198000, C544S205000, C544S206000, C544S207000, C544S208000, C544S209000
Reexamination Certificate
active
06858608
ABSTRACT:
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which inhibits telomerase. It also relates to novel chemical compounds as well as their therapeutic application in humans.
REFERENCES:
patent: 5767278 (1998-06-01), Gaeta
patent: 6150360 (2000-11-01), Daeyaert et al.
patent: 11060573 (1999-03-01), None
patent: WO 9320056 (1993-10-01), None
Alasia Marcel
Caulfield Thomas
Doerflinger Gilles
Laoui Abdelazize
Mailliet Patrick
Aventis Pharma S.A.
Balasubramanian Venkataraman
Gupta Balaram
LandOfFree
Chemical derivatives and their application as antitelomerase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical derivatives and their application as antitelomerase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical derivatives and their application as antitelomerase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3495271